PRO/AH/EDR> Ebola update (22): long-term sequelae, news, research

Ebola — Liberia
Fri 11 Mar 2016 Liberia: Zmapp is effective Ebola treatment
[Richard T. Davey, the Deputy Clinical Director in the Division of Clinical Research at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, USA, has disclosed the only clinical trial evaluating whether the experimental Ebola therapy ZMapp is safe and effective for Ebola cure. Davey said that the study has revealed that ZMapp is well tolerated and suggests it may hold some promise as an